glp 1 thanksgiving How to Navigate the Holidays on GLP-1 Medication: Physician How to Do Thanksgiving on

Second cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk

Limitations of Current Research Many studies are preclinical Human mechanistic trials remain limited Microbiome responses vary individually Diet, sleep, stress, and medications influence outcomes GLP-1 regulation is multi-factorial The microbiome is one variable within a complex endocrine network

For patients with chronic kidney disease, heart failure, or established atherosclerotic cardiovascular disease, substituting a sodium-glucose cotransporter 2 (SGLT2) inhibitor may be preferred

Season the cottage cheese with everything bagel seasoning or fresh herbs

Patients who maintain balanced nutrition, regular exercise, and healthy routines achieve better results and sustain their progress more effectively